A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL
Clinical trial NCT06314828 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06314828
- Sponsor
- Guangdong Ruishun Biotech Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2025-05-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.